Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-14
1994-01-11
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514825, 514866, 514885, 514893, A61K 31415
Patent
active
052781836
ABSTRACT:
A pharmaceutical composition for the treatment of autoimmune diseases comprising an effective amount of a compound of formula
REFERENCES:
patent: 4999367 (1991-02-01), Balocchi et al.
patent: 5112986 (1992-05-01), Baiocchi et al.
Deodhar, Sharad D., "Autoimmune Diseases", Immunology: Clinical, Fundamental, and Therapeutic Aspects, VCH Publishers, New York, (1990) pp. 296-304.
European Search Report for Patent No. EP 92 20 1037.6, (Jul. 31, 1992).
Mastrantonio et al., "Interference of Two Anti-Inflammatory Drugs, Bendazac and Phenylbutazone, On The Cellular Kinetics of the Immune response", Ann. 1st. Super. Sonita (1973) 9: pp. 138-40.
Instituto Ricerca Francesco Angelini S.p.A.
Schenkman Leonard
LandOfFree
Method for the treatment of autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631627